Surmodics Inventory Turnover Ratio 2006-2019 | SRDX

Surmodics inventory turnover ratio from 2006 to 2019. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
Surmodics Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.533B $0.100B
SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring innovation together for better patient outcomes. Recent collaborative efforts include the implementation of SurModics' Bravo drug delivery polymer matrix as a key component of the first-to-market drug-eluting coronary stent. SurModics is also active in the ophthalmology market with a sustained drug delivery system that is currently in human trials for treatment of retinal disease. A significant portion of SurModics' revenue is generated by royalties earned from the sale of our customers' commercial products.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $149.261B 20.95
Abbott Laboratories (ABT) United States $149.010B 27.18
Stryker (SYK) United States $76.714B 25.79
Boston Scientific (BSX) United States $58.945B 27.82
Baxter (BAX) United States $41.416B 25.11
EssilorLuxottica Societe Anonyme (ESLOY) France $33.904B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.822B 18.71
Terumo (TRUMY) Japan $26.925B 33.60
Coloplast (CLPBY) Denmark $25.499B 40.71
Lonza Group Ag (LZAGY) Switzerland $25.289B 0.00
ResMed (RMD) United States $21.249B 39.20
Smith & Nephew SNATS (SNN) United Kingdom $19.012B 0.00
Sunny Optical Technology (SNPTF) China $17.210B 0.00
Insulet (PODD) United States $11.282B 536.73
Bio-Rad Laboratories (BIO) United States $10.725B 51.48
Hill-Rom Holdings (HRC) United States $6.983B 20.59
Perrigo (PRGO) Ireland $6.665B 12.43
William Demant Holdings (WILYY) Denmark $6.665B 0.00
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.037B 40.79
Shandong Weigao Medical Polymer (SHWGF) China $5.382B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
Canopy Growth (CGC) Canada $4.955B 0.00
NuVasive (NUVA) United States $3.778B 29.75
ICU Medical (ICUI) United States $3.688B 24.04
Neogen (NEOG) United States $3.350B 56.05
GW Pharmaceuticals (GWPH) United Kingdom $3.165B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.147B 0.00
Quidel (QDEL) United States $2.687B 25.50
Aurora Cannabis (ACB) Canada $2.346B 0.00
National Vision Holdings (EYE) United States $2.162B 48.80
Agios Pharmaceuticals (AGIO) United States $2.128B 0.00
InMode (INMD) Israel $1.670B 0.00
Cardiovascular Systems (CSII) United States $1.522B 0.00
AtriCure (ATRC) United States $1.126B 0.00
VAREX IMAGING (VREX) United States $1.125B 22.54
Aphria (APHA) $0.961B 0.00
Phibro Animal Health (PAHC) United States $0.923B 17.28
NanoString Technologies (NSTG) United States $0.838B 0.00
Lantheus Holdings (LNTH) United States $0.825B 20.62
TG Therapeutics (TGTX) United States $0.790B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.777B 29.75
LeMaitre Vascular (LMAT) United States $0.685B 38.49
Omeros (OMER) United States $0.661B 0.00
PetIQ (PETQ) United States $0.655B 15.99
Quanterix (QTRX) United States $0.628B 0.00
Cerus (CERS) United States $0.613B 0.00
OraSure Technologies (OSUR) United States $0.484B 29.04
Owens & Minor (OMI) United States $0.419B 15.51
MacroGenics (MGNX) United States $0.413B 0.00
HEXO (HEXO) $0.409B 0.00
Utah Medical Products (UTMD) United States $0.378B 27.36
Meridian Bioscience (VIVO) United States $0.374B 12.88
Organigram Holdings (OGI) Canada $0.322B 0.00
BioLife Solutions (BLFS) United States $0.302B 123.08
Zynex (ZYXI) United States $0.299B 33.81
Vapotherm (VAPO) United States $0.244B 0.00
United Health Products (UEEC) United States $0.240B 0.00
Viemed Healthcare (VMD) United States $0.239B 0.00
Bovie Medical (APYX) United States $0.239B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.233B 0.00
Repro-Med Systems (KRMD) United States $0.164B 0.00
InfuSystems Holdings (INFU) United States $0.146B 734.00
Cytosorbents (CTSO) United States $0.133B 0.00
Rockwell Medical (RMTI) United States $0.131B 0.00
Fonar (FONR) United States $0.130B 9.18
Liberty Health Sciences (LHSIF) Canada $0.124B 0.00
Female Health (VERU) United States $0.123B 0.00
Chimerix (CMRX) United States $0.122B 0.00
United-Guardian (UG) United States $0.088B 22.24
Chembio Diagnostics (CEMI) United States $0.079B 0.00
Nephros (NEPH) United States $0.064B 0.00
MTech Acquisition (KERN) United States $0.057B 0.00
MRI Interventions (MRIC) United States $0.056B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.046B 0.00
Surface Oncology (SURF) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.018B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.009B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.003B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00